GeorgePangalos

Calamos is a global investment firm known for its work in US growth equity, convertible securities, multi-asset portfolios and alternatives. George leads growth equity coverage in the space and semiconductor sectors: three-statement models with sum-of-the-parts, DCF and scenario valuation, backlog analysis, and full investment write-ups presented to the investment committee. He started the firm's thematic work on orbital data centers and the defense procurement pipeline, advises the portfolio managers on using convertibles to express equity views, and wrote the proposal for a new fund across private equity, secondaries, co-investments and fund-of-funds allocations, which the founder endorsed.

The founder's family office. George underwrote private equity and real estate investments, originated deal flow, and built the models and variance analyses behind portfolio decisions. He screened convertible bonds and equity options for the portfolio managers, built Python tools mapping rent growth across US markets, and advised senior management by memo on deal structures and capital allocation.

George managed live deals and projects, negotiated with the sell side, and worked directly with clients on their financing needs. He built the acquisition and development models for real estate transactions in Greece, the UK, Kuwait and the United States, prepared the pitch materials that put those deals in front of investors, and presented bottom-up new product analysis and market research to senior management and the CEO.

At the world's largest listed dry bulk owner, George evaluated newbuilding vessel acquisitions and strategic initiatives through the Covid years. He built buy-side models for dry bulk and container vessel transactions, analyzed freight rates, sell-side research and fleet supply to read the market, and presented findings to senior leadership each week. This is where the shipping finance research began.

Statistical analysis of ten years of mergers and acquisitions among small and mid-cap medical firms in Greece, to estimate the odds of a successful deal, and research on how their shares behaved through the pandemic. George also introduced the firm to private clinics and hospitals as prospective partners.